These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 15582916
1. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. O'Shea M, Singh ME, McGregor IS, Mallet PE. J Psychopharmacol; 2004 Dec; 18(4):502-8. PubMed ID: 15582916 [Abstract] [Full Text] [Related]
6. Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Renard J, Krebs MO, Jay TM, Le Pen G. Psychopharmacology (Berl); 2013 Feb 28; 225(4):781-90. PubMed ID: 22983145 [Abstract] [Full Text] [Related]
7. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors. Mateos B, Borcel E, Loriga R, Luesu W, Bini V, Llorente R, Castelli MP, Viveros MP. J Psychopharmacol; 2011 Dec 28; 25(12):1676-90. PubMed ID: 20562169 [Abstract] [Full Text] [Related]
8. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Schneider M, Koch M. Neuropsychopharmacology; 2003 Oct 28; 28(10):1760-9. PubMed ID: 12888772 [Abstract] [Full Text] [Related]
9. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory. Higuera-Matas A, Botreau F, Miguéns M, Del Olmo N, Borcel E, Pérez-Alvarez L, García-Lecumberri C, Ambrosio E. Pharmacol Biochem Behav; 2009 Oct 28; 93(4):482-90. PubMed ID: 19576923 [Abstract] [Full Text] [Related]
10. Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. Braida D, Sala M. Neuroreport; 2000 Jun 26; 11(9):2025-9. PubMed ID: 10884065 [Abstract] [Full Text] [Related]
11. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment? Genn RF, Tucci S, Parikh S, File SE. Psychopharmacology (Berl); 2004 Dec 26; 177(1-2):93-9. PubMed ID: 15205871 [Abstract] [Full Text] [Related]
12. Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats. Werling LL, Reed SC, Wade D, Izenwasser S. Int J Dev Neurosci; 2009 May 26; 27(3):263-9. PubMed ID: 19167478 [Abstract] [Full Text] [Related]
14. Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo. Hill MN, Froc DJ, Fox CJ, Gorzalka BB, Christie BR. Eur J Neurosci; 2004 Aug 26; 20(3):859-63. PubMed ID: 15255998 [Abstract] [Full Text] [Related]
17. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA. Kevin RC, Wood KE, Stuart J, Mitchell AJ, Moir M, Banister SD, Kassiou M, McGregor IS. J Psychopharmacol; 2017 Jun 26; 31(6):757-769. PubMed ID: 28093016 [Abstract] [Full Text] [Related]
18. Increased anxiety and impaired spatial memory in young adult rats following adolescent exposure to methylone. Daniel JJ, Hughes RN. Pharmacol Biochem Behav; 2016 Jun 26; 146-147():44-9. PubMed ID: 27178814 [Abstract] [Full Text] [Related]
19. Cannabinoids alter recognition memory in rats. Kosiorek P, Hryniewicz A, Bialuk I, Zawadzka A, Winnicka MM. Pol J Pharmacol; 2003 Jun 26; 55(5):903-10. PubMed ID: 14704485 [Abstract] [Full Text] [Related]
20. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA, Matsuda-Matsumoto H, Iwazaki T, McGregor IS. Neuropsychopharmacology; 2008 Apr 26; 33(5):1113-26. PubMed ID: 17581536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]